Cargando…

Transpositional immunity: immunotherapeutical approach against bovine leukemia virus

Detalles Bibliográficos
Autor principal:	Roa-Castellanos, RA
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767065/ http://dx.doi.org/10.1186/1742-4690-6-S2-P78

Ejemplares similares

An efficient vaccine against bovine leukemia virus
por: Gutiérrez, Gerónimo, et al.
Publicado: (2015)

Egg yolk antibodies (IgY) against Bovine Leukemia Virus
por: Martínez, Cecilia, et al.
Publicado: (2014)

Generation of virus-like particle as a vaccine strategy against bovine leukemia virus
por: Otsuki, Hiroyuki, et al.
Publicado: (2015)

Immunotherapeutic potential of varicella vaccine in smoldering and cutaneous adult T-cell leukemia/lymphoma
por: Amano, M, et al.
Publicado: (2014)

Hyper-replicative bovine leukemia virus by mutation of an envelope N-linked glycosylation site
por: de Brogniez, A, et al.
Publicado: (2014)

P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic
por: Lykopoulos, K, et al.
Publicado: (2014)

Epitope mapping of CD8+ T cells on bovine leukemia virus Gag, Env and Tax protein in cattle with different bovine MHC DRB3 alleles
por: Bai, Lanlan, et al.
Publicado: (2015)

Comparison of systemic right ventricular function in transposition of the great arteries after atrial switch and congenitally corrected transposition of the great arteries
por: Morcos, Michael, et al.
Publicado: (2016)

Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma
por: Liu, Bai, et al.
Publicado: (2014)

A novel bovine leukemia virus peptide vaccine targeting susceptible cattle-Production by 3-D modelling and nanotechnology
por: Aida, Yoko, et al.
Publicado: (2015)

Identification of potential immunotherapeutic targets in antigen presentation and costimulation networks
por: Spaapen, Robbert, et al.
Publicado: (2014)

BLV-CoCoMo-qPCR: estimation of bovine leukemia virus (BLV) proviral load harbored by lymphocyte subpopulations in BLV-infected cattle at the subclinical stage of enzootic bovine leucosis
por: Aida, Yoko, et al.
Publicado: (2014)

P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
por: Greiner, Jochen, et al.
Publicado: (2023)

IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer
por: Bilyard, Hilary, et al.
Publicado: (2014)

Immunotherapeutic targeting of HSP90 client proteins in BRAF-inhibitor resistant melanoma
por: Fecek, Ronald J, et al.
Publicado: (2015)

Peptide microarray mapping of B cell epitopes on bovine leukemia virus and peptide ELISA analysis of conservation of epitopes in BLV infected Japanese cattle
por: Bai, Lanlan, et al.
Publicado: (2015)

Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI
por: Matsushita, Maiko, et al.
Publicado: (2015)

Colostrum replacer and bovine leukaemia virus sero-positivity
por: Choudhury, Bhudipa, et al.
Publicado: (2014)

A novel bovine leukemia virus peptide vaccine targeting susceptible cattle-Estimating vaccine effectiveness using susceptible cattle constructed by fertilized ovum transplantation
por: Takeshima, Shin-nosuke, et al.
Publicado: (2015)

Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model
por: Shafren, Darren, et al.
Publicado: (2014)

Immunomodulatory activity of SGI-110: a basis for novel chemo-immunotherapeutic combinations in cancer treatment
por: Covre, Alessia, et al.
Publicado: (2013)

Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
por: Wang, Liang-Chuan S, et al.
Publicado: (2015)

The generation and analysis of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic
por: Tsang, Kwong Y, et al.
Publicado: (2015)

A bacterial immune-prophylactic approach against asthma for infants and children
por: Loeffler, Daniela IM, et al.
Publicado: (2010)

A recombinant attenuated candidate vaccine that efficiently and persistently protects against bovine leukemia virus in herds
por: Rodríguez, Sabrina M, et al.
Publicado: (2014)

Mechanical and morphological properties of the aortic root and arch late after arterial switch operation for transposition of the great arteries
por: Ntsinjana, Hopewell, et al.
Publicado: (2012)

Elucidating the role of Bovine Leukemia Virus encoded micro-RNAs
por: Durkin, Keith, et al.
Publicado: (2014)

ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
por: Orentas, Rimas J, et al.
Publicado: (2013)

P338: SLC7A11 PROMOTES ARGININE BIOSYNTHESIS IN ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMMUNOTHERAPEUTIC POTENTIAL
por: LI, Jiazheng, et al.
Publicado: (2023)

Novel adenoviral serotype 5 based immunotherapeutic induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
por: Morse, Michael, et al.
Publicado: (2013)

Akt activation by human T-cell leukemia virus tax oncoprotein
por: Cherian, Mathew, et al.
Publicado: (2015)

P18-03. Dendritic cell-based immune therapy against HIV-1
por: Gruters, RA, et al.
Publicado: (2009)

Bovine Respiratory Disease in Finland
por: Nikunen, S., et al.
Publicado: (2003)

Accuracy and Inter observer variability of blood flow quantification on 4D flow MRI in adult with transposition of the great arteries corrected by arterial switch
por: Belhajer, Zahra, et al.
Publicado: (2016)

Calreticulin mediates immune recognition of acute myeloid leukemia cells in vivo
por: Chen, Xiufen, et al.
Publicado: (2013)

Editorial: The immune escape mechanism and novel immunotherapeutic strategies of leukemia
por: Yu, Kang, et al.
Publicado: (2023)

A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes
por: Slingluff, Craig L, et al.
Publicado: (2014)

The bovine leukemia virus microRNAs permit escape from innate immune response and contribute to viral replication in the natural host
por: Gillet, Nicolas A, et al.
Publicado: (2015)

UPAR AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN RECURRENT GLIOBLASTOMA
por: Maich, William, et al.
Publicado: (2023)

Retinal manifestations in adult T-cell leukemia/lymphoma virus type 1 (HTLV-1)
por: Merle, Harold, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nlr972o6giuqdla23dgp6k02v9